ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2021

CD200 Immune-Checkpoint Peptide Elicits an Anti-glioma Response Through the DAP10 Signaling Pathway.

Elisabet Ampudia-Mesias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.